$ORMP #Stocks #StockMarket #OramedPharmaceuticals issued Q3 EPS on https://t.co/savSNTKlN1: ORMP relized deterioration in EPS per share by -56.52 % to $0.10 and Sales decrease by -0.147 % to $0.681 MM in the Q3, Y/Y. https://t.co/7ocwjvVAnp